Thursday, July 23, 2026

 

Scientists discover genetically distinct avocados in Nicaragua that people transported from South America thousands of years ago



Using leaf samples and insights from local farmers, researchers reveal a hotbed of avocado diversity in Central America that could boost sustainable agriculture and commercial varieties




Smithsonian

Close-up of the fruits produced by a native avocado tree. 

image: 

Close-up of the fruits produced by a native avocado tree growing on the side of the road in Chiapas, Mexico.

Archaeobotanist Kevin Wann, who conducted the research as a fellow at the museum, and his colleagues examined DNA from avocado leaves collected in Nicaragua, Honduras and southern Mexico. They also spoke with the farmers and gardeners to learn how they cultivate these local avocados.

“There is a much wider breadth of avocado diversity that science had not yet documented,” said Wann, who is now pursuing his doctorate in the Department of Anthropology in the College of Arts and Sciences at Texas A&M and had never eaten an avocado before this project. “We could potentially tap into this genetic diversity to conserve commercial avocado plants that are vulnerable to disease.”

Increasing the genetic diversity of avocados is crucial to protecting the multi-billion-dollar industry surrounding the fruit. Wann thinks the trove of avocado diversity preserved in Central America’s lowlands could help protect commercial avocados from the fate of other clonal crops like bananas, which have been devastated by fungal pathogens in the past. The region’s local varieties are also adapted to warmer and wetter climates.

view more 

Credit: Kevin Wann, 2024 Missing Migrants Project

     


      

 A team of scientists led by researchers with the Smithsonian’s National Museum of Natural History and Texas A&M University recently uncovered genetic traces of ancient migration in DNA from avocados growing in Nicaragua. They found evidence that, around 5,000 years ago, people migrating north from South America carried the oversized seeds of one of their favorite fruits—avocados. As these seeds were dispersed throughout the humid lowlands of Central America, they hybridized with native varieties, producing a diversity of avocado varieties that produce the large, smooth-skinned berries that are now enjoyed around Central America. Despite resembling the avocados found in humid regions like Florida and the Caribbean, these local varieties are genetically distinct from the commercially grown fruits found in guacamole.

            In a paper published today, July 22, in the journal Plants, People, Planet, a team led by archaeobotanist Kevin Wann, who conducted the research as a fellow at the museum, examined DNA from avocado leaves collected in Nicaragua, Honduras and southern Mexico. They also spoke with the farmers and gardeners to learn how they cultivate these local avocados.

            “There is a much wider breadth of avocado diversity that science had not yet documented,” said Wann, who is now pursuing his doctorate in the Department of Anthropology in the College of Arts and Sciences at Texas A&M and had never eaten an avocado before this project. “We could potentially tap into this genetic diversity to conserve commercial avocado plants that are vulnerable to disease.”

A Crop of Clones

            The natural range of avocado trees (Persea americana) extends from Mexico to Peru. For more than 10,000 years, humans in this area have coveted the plant’s fruit, whose yellowish-green flesh is packed with nutrients and fats. These superfoods are now cultivated around the world—in 2024, growers produced more than 11 million metric tons of avocados.

            More than 80% of these avocados were a single variety known as the Hass avocado. These large, long-lasting avocados are produced through clonal grafting, where a branch is taken off one Hass avocado tree and attached to another tree to bear the same exact fruit. As a result, most avocados in grocery stores are genetically indistinguishable. This makes all Hass avocados vulnerable to the same threats. A single disease or change in temperature or precipitation can wipe out an entire population of Hass avocados.

            Increasing the genetic diversity of avocados is crucial to protecting this multi-billion-dollar industry. According to Wann, the muggy lowlands of countries like Nicaragua and Honduras are rich in avocado diversity. Here, traditional agricultural practices have honed the region’s native avocado varieties, also known as landraces, for thousands of years.

A Hotbed of Avocado Diversity

            To document the diversity of avocado landraces in Central America, Wann and his colleagues collected leaf samples from dozens of varieties in southern Mexico, Nicaragua and coastal Honduras. During the field work in southern Mexico, Wann dealt with bouts of food poisoning and was stung in the face by a wasp while collecting samples from a roadside grove of avocado trees.

            The researchers also interviewed local gardeners and rural farmers in Nicaragua and Honduras to learn more about native avocado varieties. This agricultural perspective was crucial according to Logan Kistler, the museum’s curator of archaeobotany and archaeogenomics who advised Wann during his fellowship and was the senior author of the new paper.

            “You can't think about biodiversity without considering agriculture, because it's one of the most impactful ecological activities we do,” Kistler said. “Traditional agricultural practices have shaped these plants for thousands of years.”

            During a tour of one grove in Nicaragua, a farmer offered Wann an avocado, unaware that the scientist had never tasted the fruit he studied.

            “I wanted to see how far I could go into my dissertation studying avocados without ever eating one,” he said. “I made it four years but when one of the native farmers offered me one, I couldn’t turn him down.

            “And it was delicious,” adds Wann, who now routinely enjoys guacamole.

            The locals shared valuable insights with the researchers. They confirmed that these lowland avocado landraces had not experienced root rot, the most common disease affecting commercial avocados. Some Nicaraguan farmers even graft commercial avocado branches onto native avocado trees, which are better adapted to the local environment.

Ancient Genetic Clues

            In the lab, the team extracted and analyzed DNA from the harvested leaf samples. In total, the team collected DNA from 47 native avocado landraces (32 of which came from Nicaragua). The scientists compared the DNA from the various landraces with previously published genetic data from more than 200 other avocado lineages.

            The team discovered that the avocado samples collected in southern Mexico were closely related to ancestral highland populations found in other parts of Mexico as well as commercial varieties. In contrast, the landraces sampled in the lowlands of Nicaragua were genetically tied to avocados found further south, including populations along the coast of Colombia.

            This revealed that many local landraces in this part of Central America are planted from fruits originally grown in South America. The team posits that human populations brought their local avocado varieties with them as they migrated through the Americas. Based on the genetics, this avocado relocation likely occurred around 5,000 years ago, which is roughly when other South American crops, like chocolate and certain varieties of maize, appear in the Central American archaeological record.

            Kistler thinks varieties of this fleshy fruit continued to move back and forth as ancient communities migrated over thousands of years.

            “It was a very connected landscape throughout Central and South America,” Kistler said. “It's not one big episode of people moving avocados and other food species around, it's a constant interchange.”

The Fruit’s Future

            Wann thinks the trove of avocado diversity preserved in Central America’s lowlands could help protect commercial avocados from the fate of other clonal crops like bananas, which have been devastated by fungal pathogens in the past. The region’s local landraces are also adapted to warmer and wetter climates.

            However, some of these local avocado varieties are at risk. Wann and his colleagues heard that several Nicaraguan farmers have cut down some of their local avocado trees to make more space for commercial varieties. Decreasing this ancient avocado diversity could threaten the fruit’s future.

            “These locally grown fruit trees are vital to the longevity of avocados as a species,” Wann said. “Their high levels of genetic diversity makes them more prepared to face potential shifts in climate or diseases compared to the ones you’d buy at a supermarket.”

            In addition to Wann and Kistler, the study included authors affiliated with the University of Oklahoma and California State University Long Beach. This research was supported by the Wenner-Gren Society.

About the National Museum of Natural History

            The National Museum of Natural History is connecting people everywhere with Earth’s unfolding story. It is one of the most visited natural history museums in the world. Opened in 1910, the museum is dedicated to maintaining and preserving the world’s most extensive collection of natural history specimens and human artifacts. The museum is open daily, except Dec. 25, from 10 a.m. to 5:30 p.m. Admission is free. For more information, visit the museum on its website, blog, Facebook, LinkedIn and Instagram.

# # #

 

MARYLAND: Data analysis shows no increase in mental health prescriptions after abortion



Using Danish health records, study analyzes thousands of post-abortion outcomes




University of Maryland

UMD SPH logo 

image: 

University of Maryland School of Public Health

view more 

Credit: UMD






While more women globally are using medication to have abortions, a University of Maryland-led study out today in JAMA Psychiatry found no evidence that a first medication or procedural abortion caused an increase in mental health medication use. 

Using records from the Danish health registry, researchers looked to see if a person’s first medication or procedural abortion was related to filling a mental health prescription for the first time, as a way to measure whether abortion method affects mental health. The studied group had never previously filled a mental health prescription. 

The study tracked prescriptions filled for a variety of psychiatric conditions, such as depression and anxiety, following a person’s first abortion. From one-year post-abortion and beyond, the researchers found no statistically significant increase in fulfillment of mental health medication when adjusting for multiple tests. More than five years afterwards, filling such prescriptions decreased when adjusting for multiple tests. 

“Counter to a common perception around abortion, the results showed neither medication nor procedural abortion caused the use of  psychotropic medications, which suggests that neither method increases risk of mental health issues,” said Dr. Julia Steinberg, lead author of the study and an associate professor in the Department of Family Science at UMD’s School of Public Health. 

Steinberg and her Danish colleagues analyzed thousands of Danish health records of women and girls, aged 12 to 38, who had an abortion by medication or procedure in their first trimester of pregnancy and between the years 2000 and 2018. Denmark has provided abortions through its nationalized health care since legalization in 1973. 

Researchers compared prescriptions from one year before the person’s abortion with prescriptions claimed in the first year, one to two years afterwards, two to five years afterwards, and over five years afterwards. 

The study looked at all mental health medications, treating a wide variety of conditions including sleep disorders and ADHD, as well as medications that specifically target anxiety and depression. 

“This research helps us better understand the association between abortion method and mental health. We did not investigate social factors like cultural stigmas around abortion, which could impact the mental health of a person after having an abortion, and are likely to vary by place and culture,” Steinberg said.

Within the year after a first abortion, the data showed a slight increase in psychiatric prescription use. However, after applying a common statistical adjustment necessary when analyzing a high number of variables and comparisons, researchers found the risks in that first year were no longer statistically significant. 

The study used data from the Danish population, where over 94% of people are white and where the national culture, legal framework and access to abortion and health care differs from the United States. 

“While the study focused on Danish data, the results are an important rebuttal to claims that abortion – particularly medication abortion – harms mental health,” Steinberg said.   

Steinberg co-led a 2024 study examining whether mental health disorders, measured by psychiatric diagnoses, increased after a medication or procedural abortion, finding neither abortion method increased risk of psychiatric diagnoses in the short or long-term. 

 

Availability of generic semaglutide removes barrier to affordable diabetes care, experts predict



Calculations in the Canadian Journal of Cardiology provide evidence of cost-effectiveness of therapies for patients with type 2 diabetes and high cardiorenal risk




Elsevier






July 22, 2026 – In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers predict that the anticipated price reductions of up to 70% will dramatically increase both the cost-effectiveness and health system affordability of therapy options for patients with type 2 diabetes and high cardiorenal risk. The new study in the Canadian Journal of Cardiology, published by Elsevier, provides key evidence regarding reimbursement and formulary decisions.

Generic semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), has recently become available in Canada after regulatory exclusivity for semaglutide expired in Canada in January 2026—years earlier than expected in the US and countries in Europe. Patients with type 2 diabetes and high cardiorenal risk are recommended to initiate a GLP-1RA and/or a sodium-glucose cotransporter-2 inhibitor (SGLT2i) according to Canadian and international guidelines.

The authors estimate that between 1.3 and 2.1 million people living in Canada may meet the Canadian Cardiovascular Society criteria for type 2 diabetes patients eligible to use GLP-1RAs or SGLT2is. The estimated annual cost of providing GLP-1RAs to all indicated patients would be $3.35 to $5.31 billion at pre-generic 2025 semaglutide prices. In Canada, these costs are typically paid by provincial or private drug insurance plans, but may be paid out-of-pocket when the drugs are not covered by a patient’s insurance plan.

“The high cost of brand-name versions of these GLP-1RAs has been a significant barrier to patients and provincial insurers. Anticipated price reductions from the introduction of generic semaglutide could substantially alter the health economic value of programs aimed at initiating SGLT2i and GLP-1RA therapies for patients with type 2 diabetes and high cardiorenal risk,” says first author of the study Ethan McNally, BA, McGill University School of Population and Global Health.

Using a health economic microsimulation model to project lifetime costs, quality-adjusted life years (QALYs), and the burden of cardiovascular and renal comorbidities for this high-risk patient group, the investigators examined how the cost-effectiveness of GLP-1RAs changes across a range of possible prices.

Key Economic Modeling Outcomes

Guided by the commonly used threshold of $50,000 per QALY in Canada, the most important findings are as follows:

  • At a 60% reduction from the 2025 pre-generic semaglutide price paid by the Quebec provincial drug plan, combined GLP-1RA and SGLT2i therapy may become the preferred strategy for this guideline-indicated cohort of patients, compared to either therapy alone or other standard-of-care therapies.
  • At a 70% price reduction, GLP-1RA is predicted to be cost-effective compared to non-SGLT2i standard-of-care therapies (cost-effectiveness ratio [CER] of $22,700). SGLT2i is still predicted to be preferred over GLP-1RA alone, but dual therapy is predicted to be more cost-effective than either option alone (CER of $31,700 for dual therapy vs. SGLT2i alone).

Given the rapid growth of GLP-1RA usage and their high costs, this analysis may provide evidence for reimbursement and formulary decisions. “Many provincial public drug plans limit GLP-1RA and SGLT2i reimbursement to patients who fail to meet glycemic targets. Multiple clinical guidelines now recommend these therapies for patients with type 2 diabetes at high cardiorenal risk, regardless of blood sugar levels. Given that our findings suggest that generic pricing may be cost-effective, payers could explore adjusting reimbursement criteria,” notes lead investigator Abhinav Sharma, MD, PhD, DREAM-CV Lab, Research Institute, and Centre for Outcome Research & Evaluation, McGill University Health Centre.

These findings may generalize internationally, once generic semaglutide becomes available in other countries.

Co-lead investigator Alton Russell, PhD, McGill University School of Population and Global Health, and Centre for Outcome Research & Evaluation, McGill University Health Centre, concludes, “Our results are encouraging and provide further economic justification for the use of these therapies among appropriate patients with type 2 diabetes in Canada, which will significantly improve the quality of life, lower hospitalization costs, and ultimately protect patients from heart failure and kidney disease progression.”

 

 

New membrane could make green hydrogen cheaper, tougher and easier to scale



Science China Press

Scalable PAMQ membrane enables durable green hydrogen production from single cells to kilowatt-scale stacks 

image: 

This graphic highlights the new PAMQ anion exchange membrane developed for water electrolysis. The membrane combines reduced superacid consumption during synthesis, high alkaline stability, and high device performance. It was validated in both single-cell electrolyzers and kilowatt-scale stacks, pointing to its promise for scalable green hydrogen production.

view more 

Credit: ©Science Bulletin





As countries push toward carbon neutrality, green hydrogen is increasingly seen as a key energy carrier for storing and transporting renewable electricity from intermittent sources such as solar and wind. Among the emerging technologies for producing green hydrogen, anion exchange membrane water electrolyzer (AEM-WE) are especially attractive because it can potentially combine the low-cost advantages of alkaline water electrolysis utilizing platinum-group-metal-free catalysts and the high efficiency and compact design of proton exchange membrane water electrolysis.

But one major obstacle has slowed their industrial development: the membrane itself. AEM must conduct hydroxide ions quickly while surviving harsh alkaline conditions for long periods. Many existing membranes degrade too fast, and some of the most promising synthesis routes depend heavily on large amounts of corrosive superacids, creating cost, safety, and environmental concerns that complicate scale-up.

Researchers at Westlake University have now developed a new membrane material designed to address both problems at once. The team created a poly(aryl methylquinuclidinium) membrane (PAMQ), using aldehyde-functionalized quinuclidine monomers. This molecular design makes the membrane easier to manufacture while also improving its chemical durability. Compared with conventional ketone-based routes, the new synthesis cuts the use of trifluoromethanesulfonic acid, a commonly used superacid, by 62.5%. That reduction is important not only because it lowers raw-material use, but also because it reduces the practical risks associated with handling strong acids during polymer production. The simplified process enabled pilot-scale synthesis and roll-to-roll membrane fabrication, both critical steps toward industrial manufacturing.

The membrane also showed high performance under demanding operating conditions. In alkaline stability tests, PAMQ showed negligible degradation after 10,000 h in 1 mol L−1 KOH at 80 ℃. In electrolyzer testing, the membrane delivered high current density in a fully non-platinum-group-metal system, and also operated stably for more than 2500 h at 1.0 A cm2 and 80 ℃.

To move beyond laboratory demonstration, the researchers further validated the membrane in a kilowatt-scale water electrolysis stack. The successful operation of the larger device suggests that the material may be suitable not only for fundamental research, but also for practical hydrogen production systems.

According to the researchers, the work establishes aldehyde-mediated superacid-catalyzed polyhydroxyalkylation as a useful platform for designing next-generation AEM. By linking molecular innovation with scalable processing, the study offers a possible route toward more durable and manufacturable membranes, supporting broader deployment of renewable hydrogen in a future zero-carbon economy.

 

Biochar transforms green roofs into powerful methane sinks



Five-year field study reveals biochar's enduring ability to enhance methane uptake in urban green infrastructure




Biochar Editorial Office, Shenyang Agricultural University

Biochar enhances methane uptake in engineered green roof substrate 

image: 

Biochar enhances methane uptake in engineered green roof substrate

view more 

Credit: Imrul Kayes, Md Abdul Halim & Wenxi Liao






Methane (CH₄), a potent greenhouse gas, contributes significantly to climate forcing. While urban green infrastructure, such as green roofs, offers many environmental benefits, their capacity to mitigate CH₄ emissions has remained largely unexplored. New findings demonstrate that incorporating biochar, a carbon-rich material, into engineered green roof substrates substantially boosts their ability to absorb atmospheric methane. This discovery offers a promising avenue for strengthening climate resilience in urban environments.

Green Roofs: Beyond Aesthetics to Climate Action

Green roofs are gaining recognition for moderating building energy use, managing stormwater, and supporting urban biodiversity. They also act as important carbon sinks by storing carbon in vegetation and substrates. However, the exchange of non-CO₂ greenhouse gases, particularly CH₄, from these systems has received limited attention. Traditional green roof substrates, often rich in organic matter, can even promote localized CH₄ production. Quantifying and enhancing CH₄ exchange in these engineered systems is essential for maximizing their climate benefits.

A Five-Year Field Test Uncovers Biochar's Potency

Researchers at the University of Toronto’s Green Roof Innovation Testing Laboratory (GRIT Lab II) conducted a five-year field study (2020–2024) to investigate how biochar amendment impacts CH₄, CO₂, and H₂O fluxes from extensive green roofs. The team compared biochar-amended modules (~5% v/v) with unamended controls. Measurements taken across seasons over multiple years provided unprecedented insights into the long-term effectiveness of biochar in engineered urban substrates. This extended observation period addresses a critical gap in prior research, which often focused on short-term experiments.

The core conclusion reveals that biochar-amended green roof modules consistently exhibited significantly greater CH₄ uptake than controls across all seasons. Peak uptake rates in spring 2023 were nearly fivefold higher in biochar-treated modules (−1.91 ± 0.25 nmol⋅m⁻²⋅s⁻¹) compared to controls (−0.40 ± 0.10 nmol⋅m⁻²⋅s⁻¹). Importantly, this enhanced methane uptake did not lead to increased carbon dioxide (CO₂) emissions, indicating a net positive effect on the overall gaseous carbon balance. The benefits persisted over the entire five-year observation period, although uptake slightly decreased in the final year, still remaining substantially higher than in unamended substrates.

Unpacking the Mechanisms: How Biochar Powers Methane Absorption

The observed increase in CH₄ uptake was strongly linked to biochar’s influence on substrate moisture and water vapor flux. Structural equation modeling indicated that biochar directly enhances CH₄ uptake and indirectly promotes it by improving substrate moisture retention. This creates favorable aerobic microsites for methane-oxidizing microbes by improving gas diffusivity and maintaining optimal moisture conditions. Biochar’s porous structure and surface chemistry likely provide stable habitats for methanotrophs, allowing them to thrive and efficiently convert CH₄ into CO₂.

A Multifaceted Solution for Urban Climate Resilience

The findings demonstrate that biochar can transform green roofs into active components of urban greenhouse gas mitigation strategies. The observed CH₄ uptake rates surpass those typically reported for many agricultural and urban soils, positioning biochar-amended green roofs as meaningful CH₄ sinks within city landscapes. This approach extends biochar-based climate mitigation solutions beyond conventional soils to engineered systems, offering a multifunctional design component that can simultaneously support hydrological functions, plant performance, and atmospheric CH₄ removal. Converting urban wood-waste into biochar for green roofs could also integrate with circular economy initiatives, providing durable carbon storage.

While this work examined a single biochar type and dosage, future efforts should explore dose-response relationships across various biochar feedstocks and pyrolysis conditions. Understanding the microbial communities involved through molecular analyses will further clarify the biological mechanisms driving enhanced CH₄ uptake. Implementing biochar in native plant green roofs, with their greater root depths and complex plant-microbe interactions, also presents an exciting avenue for expanding these climate benefits.

Suggested author quote for approval:

"Our five-year field study clearly shows that biochar is a game-changer for green roofs, enabling them to consistently absorb significant amounts of methane from the atmosphere. This turns green roofs into powerful, multifunctional assets in our fight against climate change, offering a tangible way for urban areas to actively contribute to greenhouse gas mitigation while also providing other well-known benefits."

Corresponding Author: Imrul Kayes or Sean C. Thomas

Original Source: https://doi.org/10.1007/s44246-026-00296-y

Contributions: Imrul Kayes and Sean C. Thomas contributed to the conceptualization of the research. Imrul Kayes, Md Abdul Halim, Wenxi Liao, Md Rezaul Karim, and Melanie A. Sifton participated in field data collection and data curation. Imrul Kayes conducted the formal data analysis and prepared the original manuscript draft. Sean C. Thomas provided validation and supervision and contributed to project administration and funding acquisition. All authors reviewed and approved the final manuscript.